Myriad Genetics Executive and Leadership Team

James Daniel, the Chief Executive Officer at Myriad Genetics, directs the company's overarching strategy and operational execution. Daniel guides the organization's mission to discover and deliver innovative molecular diagnostic tests for major diseases. This leadership role involves setting the strategic vision for research and development, ensuring alignment with market needs, and driving financial performance. Daniel oversees all major business units, fostering a culture of scientific excellence and patient-centric innovation. The Chief Executive Officer's responsibilities include managing key stakeholder relationships, including investors and the board of directors, to ensure long-term growth and market leadership. James Daniel's focus remains on expanding Myriad Genetics' portfolio of diagnostic solutions and enhancing patient access to critical health information.

Sam Raha, the President & Chief Executive Officer at Myriad Genetics, spearheads the company's strategic direction and operational oversight. Raha drives the core mission of discovering and delivering advanced molecular diagnostic tests across a spectrum of major diseases. This executive position involves leading all facets of the business, from scientific innovation to market expansion. Raha ensures that Myriad Genetics maintains its leadership in molecular diagnostics by fostering a culture of scientific rigor and commercial excellence. The President & Chief Executive Officer's duties encompass managing global operations, cultivating strategic partnerships, and guiding the company's financial health. Sam Raha is instrumental in advancing the company's commitment to improving patient outcomes through precise diagnostic insights.

Benjamin Wheeler, the Chief Financial Officer at Myriad Genetics, directs the company's financial strategy, planning, and reporting. Wheeler oversees all fiscal operations, including budgeting, forecasting, capital allocation, and investor relations, ensuring the financial health and stability of the organization. This critical role involves managing financial risks, optimizing profitability, and driving sustainable revenue growth. The Chief Financial Officer's responsibilities extend to financial compliance, accounting practices, and the strategic management of corporate assets. Benjamin Wheeler collaborates with executive leadership to support strategic decision-making through robust financial analysis and insights. Wheeler's expertise is vital in guiding Myriad Genetics' financial trajectory and maximizing shareholder value.

Mark Verratti, the Chief Operating Officer at Myriad Genetics, manages the company's day-to-day operational activities and process optimization. Verratti oversees the efficient execution of diagnostic test production, laboratory management, and supply chain logistics to ensure timely and accurate results for patients. This executive function involves implementing best practices in laboratory operations and quality control to meet stringent regulatory standards. The Chief Operating Officer's responsibilities include driving operational efficiency, managing resource allocation, and enhancing workflow productivity across all facilities. Mark Verratti works to scale operations in alignment with Myriad Genetics' growth objectives, ensuring seamless delivery of its specialized diagnostic services. Verratti's leadership focuses on maintaining high standards of operational excellence.

Mike Whittington, the President & Chairman & Chief Information Officer at Myriad Genetics, provides strategic leadership across multiple critical domains. Whittington directs the company's information technology infrastructure and digital strategy, ensuring robust and secure systems that support diagnostic operations and innovation. As Chairman, Whittington guides the board's strategic oversight and governance, fostering long-term company vision. The President role involves broad executive responsibilities, contributing to overall business development and operational alignment. Mike Whittington's dual focus on technology and corporate governance ensures that Myriad Genetics leverages information systems effectively while maintaining strong ethical and strategic direction. Whittington's leadership integrates technological advancement with corporate stewardship.

Brett Davis, the Sales Executive & President, S Club at Myriad Genetics, drives revenue generation and market penetration for specialized diagnostic services. Davis leads the sales organization, focusing on building strong relationships with healthcare providers and expanding the adoption of Myriad Genetics' innovative testing solutions. This role involves developing and executing strategic sales plans to achieve ambitious commercial targets and enhance market share. The Sales Executive & President, S Club's responsibilities include managing sales teams, identifying new business opportunities, and ensuring exceptional customer service. Brett Davis is dedicated to expanding the reach of Myriad Genetics' diagnostic offerings, contributing directly to the company's growth and its mission to improve patient health outcomes through advanced molecular diagnostics.

Melissa Gonzales, the President, Women's Health, Myriad Genetics, directs the strategic growth and operational success of the Women's Health division. Gonzales oversees the development, marketing, and commercialization of specialized diagnostic tests focused on women's health conditions, ensuring alignment with patient needs and market opportunities. This leadership position involves managing a dedicated team, fostering innovation within the division, and driving revenue growth. The President, Women's Health, Myriad Genetics' responsibilities include cultivating key partnerships within the healthcare ecosystem and ensuring the highest standards of product quality and customer support. Melissa Gonzales is committed to advancing women's health through precise and accessible molecular diagnostics, reinforcing Myriad Genetics' commitment to diverse disease areas.

Joel Schwartz, the President at Myriad Genetics, holds a broad executive mandate focused on driving strategic initiatives and operational excellence across key business segments. Schwartz oversees critical functions aimed at advancing the company's mission of discovering and delivering innovative molecular diagnostic tests for major diseases. This leadership role involves collaborating with other executives to refine corporate strategy, enhance market positioning, and ensure efficient resource deployment. The President's responsibilities include fostering cross-functional collaboration, identifying growth opportunities, and ensuring the effective execution of business plans. Joel Schwartz's contributions are vital to Myriad Genetics' sustained success and its commitment to improving patient care through advanced diagnostics.

Kevin Haas, the Chief Technology Officer at Myriad Genetics, architects the company's technological infrastructure and innovation pipeline. Haas directs the development and implementation of cutting-edge molecular diagnostic technologies, ensuring Myriad Genetics remains at the forefront of scientific discovery. This role involves overseeing all aspects of information technology, data science, and bioinformatics to support the company's research and diagnostic services. The Chief Technology Officer's responsibilities include driving digital transformation initiatives, enhancing cybersecurity measures, and optimizing laboratory automation. Kevin Haas collaborates closely with research and development teams to translate scientific breakthroughs into scalable diagnostic solutions. By managing technological advancements, Haas ensures the efficiency and accuracy of Myriad Genetics' testing platforms.

Shereen Solaiman, the Chief People Officer at Myriad Genetics, leads the company's human capital strategy and organizational development. Solaiman oversees all aspects of talent management, including recruitment, employee engagement, compensation, benefits, and professional development, fostering a high-performance culture. This executive position is crucial for attracting, retaining, and nurturing the skilled workforce essential for Myriad Genetics' scientific and commercial success. The Chief People Officer's responsibilities include developing and implementing HR policies that align with the company's mission and values, ensuring a supportive and inclusive work environment. Shereen Solaiman plays a key part in shaping the employee experience and driving organizational effectiveness. Solaiman's strategic approach to people management supports Myriad Genetics' innovation and growth.